Agilent Technologies, Inc. (NYSE:A) Shares Acquired by Brown Shipley& Co Ltd

Brown Shipley& Co Ltd increased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 1.3% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 31,017 shares of the medical research company’s stock after buying an additional 385 shares during the quarter. Agilent Technologies comprises about 1.8% of Brown Shipley& Co Ltd’s holdings, making the stock its 19th largest position. Brown Shipley& Co Ltd’s holdings in Agilent Technologies were worth $4,021,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Gilbert & Cook Inc. lifted its holdings in shares of Agilent Technologies by 12.5% in the 4th quarter. Gilbert & Cook Inc. now owns 2,872 shares of the medical research company’s stock valued at $399,000 after buying an additional 320 shares during the period. Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Agilent Technologies by 6.8% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 12,621 shares of the medical research company’s stock worth $1,755,000 after purchasing an additional 807 shares during the last quarter. Orion Portfolio Solutions LLC grew its position in shares of Agilent Technologies by 19.2% in the fourth quarter. Orion Portfolio Solutions LLC now owns 11,033 shares of the medical research company’s stock valued at $1,472,000 after purchasing an additional 1,774 shares during the period. Stifel Financial Corp increased its stake in Agilent Technologies by 9.6% in the fourth quarter. Stifel Financial Corp now owns 131,080 shares of the medical research company’s stock valued at $18,229,000 after purchasing an additional 11,498 shares during the last quarter. Finally, California State Teachers Retirement System lifted its position in Agilent Technologies by 1.0% during the fourth quarter. California State Teachers Retirement System now owns 469,486 shares of the medical research company’s stock worth $65,273,000 after buying an additional 4,788 shares during the period. Institutional investors and hedge funds own 87.42% of the company’s stock.

Agilent Technologies Trading Up 0.9 %

NYSE A opened at $148.06 on Monday. The company’s fifty day simple moving average is $138.91 and its 200-day simple moving average is $138.99. The stock has a market cap of $43.20 billion, a P/E ratio of 35.00, a PEG ratio of 6.48 and a beta of 1.05. Agilent Technologies, Inc. has a 52 week low of $96.80 and a 52 week high of $155.35. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the prior year, the company posted $1.43 EPS. The firm’s revenue for the quarter was down 5.6% on a year-over-year basis. Equities research analysts predict that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st will be issued a dividend of $0.236 per share. This represents a $0.94 annualized dividend and a yield of 0.64%. The ex-dividend date of this dividend is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio is currently 22.22%.

Analyst Upgrades and Downgrades

A has been the subject of several recent analyst reports. Barclays lifted their price target on Agilent Technologies from $125.00 to $135.00 and gave the company an “underweight” rating in a report on Friday, August 23rd. Bank of America increased their target price on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. Stifel Nicolaus reissued a “buy” rating and set a $151.00 price target on shares of Agilent Technologies in a research report on Monday, August 26th. UBS Group raised their price objective on Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Finally, Evercore ISI lifted their price objective on Agilent Technologies from $130.00 to $135.00 and gave the company an “in-line” rating in a research note on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $142.93.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $140.00, for a total value of $274,120.00. Following the completion of the transaction, the chief executive officer now owns 26,076 shares in the company, valued at approximately $3,650,640. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction on Friday, July 26th. The shares were sold at an average price of $140.00, for a total transaction of $274,120.00. Following the sale, the chief executive officer now directly owns 26,076 shares of the company’s stock, valued at $3,650,640. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 13,906 shares of company stock worth $2,006,580. 0.33% of the stock is currently owned by corporate insiders.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.